Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Yueping Li, Zhiwei Xie, Weiyin Lin, Weiping Cai, Chunyan Wen, Yujuan Guan, Xiaoneng Mo, Jian Wang, Yaping Wang, Ping Peng, Xudan Chen, Wenxin Hong, Guangming Xiao, Jinxin Liu, Lieguang Zhang, Fengyu Hu, Feng Li, Fuchun Zhang, Xilong Deng, Linghua Li
Topics & Concepts
LopinavirCoronavirus disease 2019 (COVID-19)RitonavirLopinavir/ritonavir2019-20 coronavirus outbreakRandomized controlled trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePandemicVirologyInternal medicineHuman immunodeficiency virus (HIV)OutbreakViral loadAntiretroviral therapyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsSARS-CoV-2 and COVID-19 Research